SF Healthcare Week: Wave Life Sciences CEO Paul Bolno discusses the company's INHBE obesity program, AATD, PNPLA3, and more
Jan 15, 2026
14:19
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
He describes the 'best-in-class' profile he believes INHBE can show in the obesity space. Plus the latest on other programs and how Wave is working on a new a new bifunctional modality.
BiotechTV - News